Deoxycholate inhibits in vivo butyrate-mediated BrDU labeling of the colonic crypt

Omaida C Velazquez, Renée W. Seto, Allison M. Bain, Jason Fisher, John L. Rombeau

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The short-chain fatty acid butyrate (NaBu) selectively increases colonic crypt base proliferation and inhibits 'premalignant' crypt surface hyperproliferation while the secondary bile acid deoxycholate (DCA) induces surface hyperproliferation, in vitro. We hypothesized that NaBu and DCA have similar selective and antagonistic effects on the colonic crypt proliferative pattern, in vivo. Fifty-six adult SD rats underwent surgical isolation of the colon and 24-hr intraluminal instillation with physiological (10 mM) and pharmacological (25 mM) levels of butyrate alone or combined with a physiological DCA level (5 μM). Bromodeoxyuridine-labeling indices (LI) were determined as labeled cells divided by total cells, for the whole crypt and five crypt compartments from base to surface. Treatment with NaBu increased total LI when compared to NaCl. This effect was significant only at the crypt base. Both doses of NaBu resulted in similar LI with no further response at the higher concentration. In contrast to prior in vitro studies, DCA alone at this concentration did not affect LI, but when combined with NaBu, DCA inhibited the effects of NaBu at the crypt base and surface. The conclusions are: (1) the in vivo proliferative effects of NaBu are selective to the crypt base, (2) an in vivo low physiological DCA level does not promote crypt surface hyperproliferation but does inhibit butyrate's proliferative effect, and (3) NaBu and DCA interact in a complex and antagonistic manner to selectively modulate crypt base and surface proliferation, in the rat colon, in vivo. These findings may have clinical relevance since colonic levels of NaBu and DCA are affected by diet.

Original languageEnglish
Pages (from-to)344-348
Number of pages5
JournalJournal of Surgical Research
Volume69
Issue number2
DOIs
StatePublished - May 1 1997
Externally publishedYes

Fingerprint

Deoxycholic Acid
Butyrates
Colon
Volatile Fatty Acids
Bromodeoxyuridine
Bile Acids and Salts
Pharmacology
Diet

ASJC Scopus subject areas

  • Surgery

Cite this

Deoxycholate inhibits in vivo butyrate-mediated BrDU labeling of the colonic crypt. / Velazquez, Omaida C; Seto, Renée W.; Bain, Allison M.; Fisher, Jason; Rombeau, John L.

In: Journal of Surgical Research, Vol. 69, No. 2, 01.05.1997, p. 344-348.

Research output: Contribution to journalArticle

Velazquez, Omaida C ; Seto, Renée W. ; Bain, Allison M. ; Fisher, Jason ; Rombeau, John L. / Deoxycholate inhibits in vivo butyrate-mediated BrDU labeling of the colonic crypt. In: Journal of Surgical Research. 1997 ; Vol. 69, No. 2. pp. 344-348.
@article{0a33ca7f6eb44b64b4d01d656ab91cd6,
title = "Deoxycholate inhibits in vivo butyrate-mediated BrDU labeling of the colonic crypt",
abstract = "The short-chain fatty acid butyrate (NaBu) selectively increases colonic crypt base proliferation and inhibits 'premalignant' crypt surface hyperproliferation while the secondary bile acid deoxycholate (DCA) induces surface hyperproliferation, in vitro. We hypothesized that NaBu and DCA have similar selective and antagonistic effects on the colonic crypt proliferative pattern, in vivo. Fifty-six adult SD rats underwent surgical isolation of the colon and 24-hr intraluminal instillation with physiological (10 mM) and pharmacological (25 mM) levels of butyrate alone or combined with a physiological DCA level (5 μM). Bromodeoxyuridine-labeling indices (LI) were determined as labeled cells divided by total cells, for the whole crypt and five crypt compartments from base to surface. Treatment with NaBu increased total LI when compared to NaCl. This effect was significant only at the crypt base. Both doses of NaBu resulted in similar LI with no further response at the higher concentration. In contrast to prior in vitro studies, DCA alone at this concentration did not affect LI, but when combined with NaBu, DCA inhibited the effects of NaBu at the crypt base and surface. The conclusions are: (1) the in vivo proliferative effects of NaBu are selective to the crypt base, (2) an in vivo low physiological DCA level does not promote crypt surface hyperproliferation but does inhibit butyrate's proliferative effect, and (3) NaBu and DCA interact in a complex and antagonistic manner to selectively modulate crypt base and surface proliferation, in the rat colon, in vivo. These findings may have clinical relevance since colonic levels of NaBu and DCA are affected by diet.",
author = "Velazquez, {Omaida C} and Seto, {Ren{\'e}e W.} and Bain, {Allison M.} and Jason Fisher and Rombeau, {John L.}",
year = "1997",
month = "5",
day = "1",
doi = "10.1006/jsre.1997.5075",
language = "English",
volume = "69",
pages = "344--348",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Deoxycholate inhibits in vivo butyrate-mediated BrDU labeling of the colonic crypt

AU - Velazquez, Omaida C

AU - Seto, Renée W.

AU - Bain, Allison M.

AU - Fisher, Jason

AU - Rombeau, John L.

PY - 1997/5/1

Y1 - 1997/5/1

N2 - The short-chain fatty acid butyrate (NaBu) selectively increases colonic crypt base proliferation and inhibits 'premalignant' crypt surface hyperproliferation while the secondary bile acid deoxycholate (DCA) induces surface hyperproliferation, in vitro. We hypothesized that NaBu and DCA have similar selective and antagonistic effects on the colonic crypt proliferative pattern, in vivo. Fifty-six adult SD rats underwent surgical isolation of the colon and 24-hr intraluminal instillation with physiological (10 mM) and pharmacological (25 mM) levels of butyrate alone or combined with a physiological DCA level (5 μM). Bromodeoxyuridine-labeling indices (LI) were determined as labeled cells divided by total cells, for the whole crypt and five crypt compartments from base to surface. Treatment with NaBu increased total LI when compared to NaCl. This effect was significant only at the crypt base. Both doses of NaBu resulted in similar LI with no further response at the higher concentration. In contrast to prior in vitro studies, DCA alone at this concentration did not affect LI, but when combined with NaBu, DCA inhibited the effects of NaBu at the crypt base and surface. The conclusions are: (1) the in vivo proliferative effects of NaBu are selective to the crypt base, (2) an in vivo low physiological DCA level does not promote crypt surface hyperproliferation but does inhibit butyrate's proliferative effect, and (3) NaBu and DCA interact in a complex and antagonistic manner to selectively modulate crypt base and surface proliferation, in the rat colon, in vivo. These findings may have clinical relevance since colonic levels of NaBu and DCA are affected by diet.

AB - The short-chain fatty acid butyrate (NaBu) selectively increases colonic crypt base proliferation and inhibits 'premalignant' crypt surface hyperproliferation while the secondary bile acid deoxycholate (DCA) induces surface hyperproliferation, in vitro. We hypothesized that NaBu and DCA have similar selective and antagonistic effects on the colonic crypt proliferative pattern, in vivo. Fifty-six adult SD rats underwent surgical isolation of the colon and 24-hr intraluminal instillation with physiological (10 mM) and pharmacological (25 mM) levels of butyrate alone or combined with a physiological DCA level (5 μM). Bromodeoxyuridine-labeling indices (LI) were determined as labeled cells divided by total cells, for the whole crypt and five crypt compartments from base to surface. Treatment with NaBu increased total LI when compared to NaCl. This effect was significant only at the crypt base. Both doses of NaBu resulted in similar LI with no further response at the higher concentration. In contrast to prior in vitro studies, DCA alone at this concentration did not affect LI, but when combined with NaBu, DCA inhibited the effects of NaBu at the crypt base and surface. The conclusions are: (1) the in vivo proliferative effects of NaBu are selective to the crypt base, (2) an in vivo low physiological DCA level does not promote crypt surface hyperproliferation but does inhibit butyrate's proliferative effect, and (3) NaBu and DCA interact in a complex and antagonistic manner to selectively modulate crypt base and surface proliferation, in the rat colon, in vivo. These findings may have clinical relevance since colonic levels of NaBu and DCA are affected by diet.

UR - http://www.scopus.com/inward/record.url?scp=0031147715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031147715&partnerID=8YFLogxK

U2 - 10.1006/jsre.1997.5075

DO - 10.1006/jsre.1997.5075

M3 - Article

C2 - 9224404

AN - SCOPUS:0031147715

VL - 69

SP - 344

EP - 348

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 2

ER -